Oligometastatic head and neck cancer: Comprehensive review
T Vengaloor Thomas, S Packianathan, E Bhanat… - Head & …, 2020 - Wiley Online Library
There are limited data available regarding the management of oligometastatic squamous
cell carcinoma of the head and neck (SCCHN) patients, and no consensus guidelines are …
cell carcinoma of the head and neck (SCCHN) patients, and no consensus guidelines are …
Use of multi-site radiation therapy for systemic disease control
RR Patel, V Verma, HB Barsoumian, MS Ning… - International Journal of …, 2021 - Elsevier
Metastatic cancer is a heterogeneous entity, some of which could benefit from local
consolidative radiation therapy (RT). Although randomized evidence is growing in support of …
consolidative radiation therapy (RT). Although randomized evidence is growing in support of …
[HTML][HTML] Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: a multi-institutional pooled analysis
JC Hong, DN Ayala-Peacock, J Lee, AW Blackstock… - PloS one, 2018 - journals.plos.org
Background Radiotherapy is increasingly used to treat oligometastatic patients. We sought
to identify prognostic criteria in oligometastatic patients undergoing definitive …
to identify prognostic criteria in oligometastatic patients undergoing definitive …
Stereotactic ablative radiation therapy for pulmonary metastases: histology, dose, and indication matter
Purpose To assess the association between colorectal cancer (CRC) histology, dose, and
local failure (LF) after stereotactic ablative radiation therapy (SABR) for pulmonary …
local failure (LF) after stereotactic ablative radiation therapy (SABR) for pulmonary …
Potent half-sandwich Ru (Ⅱ) N^ N (aryl-BIAN) complexes: Lysosome-mediated apoptosis, in vitro and in vivo anticancer activities
Z Xu, J Huang, D Kong, Y Yang, L Guo, X Jia… - European Journal of …, 2020 - Elsevier
Herein a new series of organometallic half-sandwich Ru (Ⅱ) complexes bearing aryl-BIAN
chelating ligands with various electron-withdrawing and electron-donating substituents have …
chelating ligands with various electron-withdrawing and electron-donating substituents have …
Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases
NH Lester-Coll, AP Dosoretz, WJ Magnuson… - Journal of …, 2016 - thejns.org
OBJECTIVE The JLGK0901 study found that stereotactic radiosurgery (SRS) is a safe and
effective treatment option for treating up to 10 brain metastases. The purpose of this study is …
effective treatment option for treating up to 10 brain metastases. The purpose of this study is …
Concern over cost of and access to cancer treatments: a meta-narrative review of nivolumab and pembrolizumab studies
CRP da Veiga, CP da Veiga… - Critical reviews in …, 2018 - Elsevier
Background A better understanding of the modulation of the immune system has resulted in
the development of new classes of antitumor agents such as nivolumab and …
the development of new classes of antitumor agents such as nivolumab and …
Practical considerations of single-fraction stereotactic ablative radiotherapy to the lung
Stereotactic ablative radiotherapy (SABR) is a well-established treatment for patients with
medically inoperable early-stage non-small cell lung cancer (NSCLC) and pulmonary …
medically inoperable early-stage non-small cell lung cancer (NSCLC) and pulmonary …
[HTML][HTML] Stereotactic ablative radiotherapy and systemic treatments for extracerebral oligometastases, oligorecurrence, oligopersistence and oligoprogression from …
M Kissel, I Martel-Lafay, J Lequesne, JC Faivre… - BMC cancer, 2019 - Springer
Background Stereotactic irradiation (SBRT) is a standard of care for inoperable stage I lung
cancer and brain oligometastases from lung cancer but is controversial for extracranial …
cancer and brain oligometastases from lung cancer but is controversial for extracranial …
The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going?
The spectrum hypothesis posits that there are distinct clinical states of metastatic
progression. Early data suggest that aggressive treatment of more biologically indolent …
progression. Early data suggest that aggressive treatment of more biologically indolent …